✨ Medicines Distribution Consents




1 OCTOBER NEW ZEALAND GAZETTE 3267

Schedule

Name and Strength Form Name and Address of Manufacturer Proprietary Name (if any)
Ibuprofen 200 mg Capsule R P Scherer Pty Limited, Huntingdale, Melbourne, Australia Act-3
Dexfenfluramine 15 mg Capsule Les Laboratories Servier, Gidy, Fleury-les-Aubrais, France or Alphapharm Pty Limited, Carole Park, Queensland, Australia Adifax
Carboplatin 50 mg in 5 ml, 150 mg in 15 ml, 450 mg in 45 ml Injection Delta West Pty Limited, Bentley, Western Australia Carboplatin injection
Cyclophosphamide monohydrate 100 mg, 200 mg, 500 mg, 1000 mg Powder for reconstitution for injection Pharmachemie BV, Waardeweg 78, Haarlem, The Netherlands, and Pharmachemie BV, Swensweg 5, Haarlem, The Netherlands Cyclophosphamide
Cefazolin sodium 500 mg/10 ml, 1 g/10 ml, 500 mg/100 ml, 1 g/100 ml, 10 g/100 ml Powder for reconstitution for injection (vials) Lyphomed, Grand Island, New York, United States of America Sterile Cefazolin Sodium
Naloxone hydrochloride 0.4 mg in 1 ml Solution for injection David Bull Laboratories Pty Limited, Mulgrave North, Victoria, Australia Naloxone hydrochloride injection Elafth
Lithium succinate 8% w/w Ointment J Pickles & Sons, Knaresborough, Yorkshire, England
Zinc sulphate 0.05% w/w
Chlorhexidine gluconate 0.01% w/v Solution Delta West Pty Limited, Bentley, Western Australia Antiseptic Bladder Irrigation
Sodium valproate 200 mg, 500 mg Enteric coated tablets Pacific Pharmaceuticals Limited, Mount Wellington, Auckland Epilim 200 Epicon 500
Propafenone hydrochloride 150 mg, 300 mg Tablets Knoll, AG, Ludwigshafen, Germany Rytmonorm
Vigabatrin 500 mg Tablet Merrell Dow France SA, Bourgoin-Jallieu, Cedex, France Sabril

Dated this 25th day of September 1992.

C. LOVELACE, Director-General of Health, pursuant to delegation given by the Minister of Health on the 5th day of June 1991.

go8891

Consent to the Distribution of New Related Products

Pursuant to section 96 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new related products set out in the Schedule hereto:

Schedule

Name and Strength Form Name and Address of Manufacturer Proprietary Name (if any)
Chlorhexidine gluconate 0.5% w/w Antiseptic solution Johnson & Johnson Medical Pty Limited, North Ryde, New South Wales, Australia Novacol Tincture
Paraffin liquid 95% v/v Bath oil Hamilton Laboratories Pty Limited, Adelaide, South Australia Bath Oil

Dated this 25th day of September 1992.

C. LOVELACE, Director-General of Health, pursuant to delegation given by the Minister of Health on the 5th day of June 1991.

go8892

Consent to the Distribution of a Changed Medicine

Pursuant to section 24 (5) of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the changed medicine set out in the Schedule hereto:

Schedule

Name and Strength Form Name and Address of Manufacturer Proprietary Name (if any)
Nicotine 0.83 mg/cmΒ² Patch Kabi Pharmacia Operations AS, HillerΓΈd, Denmark Nicorette Transdermal Delivery Service

Dated this 25th day of September 1992.

C. LOVELACE, Director-General of Health, pursuant to delegation given by the Minister of Health on the 5th day of June 1991.



Next Page →

PDF embedding disabled (Crown copyright)

View this page online at:


VUW Te Waharoa PDF NZ Gazette 1992, No 158


NZLII PDF NZ Gazette 1992, No 158





✨ LLM interpretation of page content

πŸ₯ Consent to Distribution of New Medicines (continued from previous page)

πŸ₯ Health & Social Welfare
25 September 1992
Medicines Act, New Medicines, Distribution
  • C. Lovelace, Director-General of Health

πŸ₯ Consent to the Distribution of New Related Products

πŸ₯ Health & Social Welfare
25 September 1992
Medicines Act, New Related Products, Distribution
  • C. Lovelace, Director-General of Health

πŸ₯ Consent to the Distribution of a Changed Medicine

πŸ₯ Health & Social Welfare
25 September 1992
Medicines Act, Changed Medicine, Distribution
  • C. Lovelace, Director-General of Health